RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 42 filers reported holding RAIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,405,399 | -27.5% | 1,648,215 | -33.6% | 0.42% | -23.8% |
| Q4 2022 | $19,868,952 | +63.9% | 2,483,619 | 0.0% | 0.56% | +58.5% |
| Q3 2022 | $12,120,000 | -12.2% | 2,483,619 | 0.0% | 0.35% | -18.7% |
| Q2 2022 | $13,809,000 | +9.7% | 2,483,619 | 0.0% | 0.43% | +71.8% |
| Q1 2022 | $12,592,000 | -80.3% | 2,483,619 | -50.0% | 0.25% | -48.9% |
| Q4 2021 | $63,978,000 | +68.6% | 4,967,238 | +95.8% | 0.49% | -10.5% |
| Q3 2021 | $37,954,000 | -51.9% | 2,537,019 | -50.0% | 0.55% | +7.6% |
| Q2 2021 | $78,850,000 | – | 5,074,038 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
| Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
| BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
| Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
| Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
| Logos Global Management LP | 134,194 | $680,000 | 0.09% |
| Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
| Woodline Partners LP | 119,700 | $607,000 | 0.01% |
| Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |